FOXO Technologies Inc.
corporate_fare Company Profile
FOXO Technologies Inc. (OTC:FOXO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 11 items for FOXO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-28, rated 7/10. Across its 11 most recent items scored 7 or higher, the top rating is 10/10, with 9 rated 8 or above. Recent SEC coverage for FOXO spans 8-K, 10-K, PRE 14C, 424B3.
Recent high-impact activity:
- FOXO Technologies Licenses Epigenetics IP, Secures Royalties and 40% Equity Option
- FOXO Technologies Reports 63% Revenue Growth to $5.17M, Net Loss Widens to $1.45M in Q1
- FOXO Technologies Authorizes 25 Billion New Shares Amid Going Concern Warning
- FOXO Technologies Faces Imminent Collapse: Going Concern Doubts, FINRA Blocks Reverse Split, and Massive Dilution Threat
- Majority Shareholder Approves 150% Increase in Authorized Shares for FOXO Technologies
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 3,062 shares in FOXO as of the September 15, 2026 settlement, a 6.8% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 1, 2026, 79.4% of FOXO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for FOXO, detected from its recent SEC filings · based on capital-structure filings through 2026-04-20.
Massive Share Authorization · Addresses Going Concern
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →